Renal Denervation in Refractory Hypertension
A phase 3 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 106 participants.
Also called NCT01560312
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 106 participants
- Sponsor
- Registry
-
NCT01560312
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Czechia
- Registry status
- Terminated
Technical summary
Registry record NCT01560312. Randomized; no masking; primary purpose treatment. Start 2011-10 (registry gives no type); primary completion 2014-02 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Renal Denervation in Refractory Hypertension
- Acronym
- PRAGUE-15
- Condition
- Hypertension
- Condition
- Resistant to Conventional Therapy
- Intervention (Device)
- Renal denervation (Symplicity® Catheter System™)
- Lead sponsor
- Charles University, Czech Republic
- Collaborator
- General University Hospital, Prague
- Collaborator
- University Hospital Olomouc
- Collaborator
- Cardiocenter Podlesí, Trinec, Czech Republic
Record details
- Record id
cardio:ct-nct01560312- Content hash
60459f37eb32fdacb42792cf9830d076cbded8ed41ffd2147f564671b448d50a